Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.35% | 62.98 | 1.0% | $472.19m | |
| AMGN | Amgen, Inc. | 0.41% | 241.49 | 1.3% | $448.51m | |
| BIIB | Biogen, Inc. | -0.22% | 285.50 | 1.4% | $387.69m | |
| ILMN | Illumina, Inc. | -0.38% | 324.72 | 3.5% | $323.34m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.14% | 235.83 | 1.9% | $300.14m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.10% | 385.94 | 2.6% | $230.50m | |
| EXAS | EXACT Sciences Corp. | -1.92% | 88.06 | 24.0% | $205.44m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.68% | 113.27 | 2.0% | $195.57m | |
| ITCI | Intra-Cellular Therapies, Inc. | -1.43% | 26.25 | 9.0% | $173.00m | |
| INCY | Incyte Corp. | -0.15% | 80.50 | 2.5% | $148.96m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.84% | 127.90 | 14.6% | $138.72m | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | -1.21% | 56.42 | 11.3% | $132.45m | |
| SGEN | Seattle Genetics, Inc. | 1.25% | 109.00 | 6.1% | $122.98m | |
| A | Agilent Technologies, Inc. | 0.79% | 90.17 | 1.6% | $113.52m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.97% | 88.27 | 4.3% | $108.30m |
Company Profile
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.